Company intelligence / Profile preview

Qureator

San Diego, California, United Statesqureator.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Qureator develops and commercializes microphysiological systems ("Curiochips") that recapitulate human tissue microenvironments in vitro. Their organ-on-a-chip platforms are used for disease modeling, drug screening, target validation, biomarker discovery, and patient stratification. The company partners with pharma/biotech companies as well as regulatory agencies to provide clinically relevant models but does not itself develop therapeutics.

Therapeutic areas: OtherOncology
Modalities: Device
Industry: Non-Drug Biotech

Partnerships

Collaborations with pharmaceutical companiesFDANIH

Beyond the preview

Go deeper on Qureator.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qureator.

Explore the full profile